Literature DB >> 11165923

Secretion of different listeriolysin cognates by recombinant attenuated Salmonella typhimurium: superior efficacy of haemolytic over non-haemolytic constructs after oral vaccination.

J Hess1, L Grode, I Gentschev, J Fensterle, G Dietrich, W Goebel, S H Kaufmann.   

Abstract

Viable antigen (Ag) delivery systems expressing defined pathogen-derived proteins represent powerful candidates for future vaccination strategies. Here, recombinant (r)Salmonella typhimurium aroA strains secreting listeriolysin (Hly) of Listeria monocytogenes in haemolytic or non-haemolytic form were constructed to direct these carriers into cytosolic or phagosomal host cell compartments, respectively. Oral and intravenous (i.v.) vaccination of mice with either construct induced 'transporter associated with antigen processing'-dependent protection against the intracellular bacterial pathogen L. monocytogenes. Comparison of oral immunization with both rSalmonella constructs revealed superior vaccine efficacy of the haemolytic rS. typhimurium Hlys construct as compared to the non-haemolytic rSalmonella Hlys(492) strain. In contrast, efficacy of i.v. vaccination with either rSalmonella strain did not significantly differ. Therefore, rSalmonella strains secreting biologically active Hly represent valuable delivery systems for heterologous rAg or DNA which should be exploited for future mucosal vaccination strategies.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11165923     DOI: 10.1016/s1286-4579(00)01333-2

Source DB:  PubMed          Journal:  Microbes Infect        ISSN: 1286-4579            Impact factor:   2.700


  7 in total

Review 1.  Bacterial infectious disease control by vaccine development.

Authors:  Roy Curtiss
Journal:  J Clin Invest       Date:  2002-10       Impact factor: 14.808

2.  Relief from Zmp1-mediated arrest of phagosome maturation is associated with facilitated presentation and enhanced immunogenicity of mycobacterial antigens.

Authors:  Pål Johansen; Antonia Fettelschoss; Beat Amstutz; Petra Selchow; Ying Waeckerle-Men; Peter Keller; Vojo Deretic; Leonhard Held; Thomas M Kündig; Erik C Böttger; Peter Sander
Journal:  Clin Vaccine Immunol       Date:  2011-04-06

3.  Protection against Leptospira interrogans sensu lato challenge by DNA immunization with the gene encoding hemolysin-associated protein 1.

Authors:  C Branger; B Chatrenet; A Gauvrit; F Aviat; A Aubert; J M Bach; G André-Fontaine
Journal:  Infect Immun       Date:  2005-07       Impact factor: 3.441

4.  Efficacy of a Lactococcus lactis ΔpyrG vaccine delivery platform expressing chromosomally integrated hly from Listeria monocytogenes.

Authors:  Mohammed Bahey-El-Din; Pat G Casey; Brendan T Griffin; Cormac Gm Gahan
Journal:  Bioeng Bugs       Date:  2010 Jan-Feb

5.  Analysis of type II secretion of recombinant pneumococcal PspA and PspC in a Salmonella enterica serovar Typhimurium vaccine with regulated delayed antigen synthesis.

Authors:  Wei Xin; Soo-Young Wanda; Yuhua Li; Shifeng Wang; Hua Mo; Roy Curtiss
Journal:  Infect Immun       Date:  2008-05-05       Impact factor: 3.441

6.  Salmonella enterica serovar typhimurium expressing a chromosomally integrated copy of the Bacillus anthracis protective antigen gene protects mice against an anthrax spore challenge.

Authors:  Helen S Garmory; Richard W Titball; Kate F Griffin; Ulrike Hahn; Reinhard Böhm; Wolfgang Beyer
Journal:  Infect Immun       Date:  2003-07       Impact factor: 3.441

7.  Lactococcus lactis-expressing listeriolysin O (LLO) provides protection and specific CD8(+) T cells against Listeria monocytogenes in the murine infection model.

Authors:  Mohammed Bahey-El-Din; Pat G Casey; Brendan T Griffin; Cormac G M Gahan
Journal:  Vaccine       Date:  2008-08-06       Impact factor: 3.641

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.